Mackenzie Financial’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.02M Buy
70,427
+26,742
+61% +$1.15M ﹤0.01% 823
2025
Q4
$1.92M Buy
43,685
+5,290
+14% +$219K ﹤0.01% 885
2025
Q3
$1.59M Sell
38,395
-60,913
-61% -$2.45M ﹤0.01% 920
2025
Q2
$4.38M Sell
99,308
-166,802
-63% -$6.67M 0.01% 635
2025
Q1
$9.82M Sell
266,110
-61,906
-19% -$2.21M 0.01% 462
2024
Q4
$10.9M Sell
328,016
-75,522
-19% -$2.45M 0.01% 454
2024
Q3
$10.5M Sell
403,538
-29,773
-7% -$740K 0.01% 435
2024
Q2
$9.74M Buy
433,311
+166,057
+62% +$3.68M 0.01% 433
2024
Q1
$6.34M Buy
267,254
+42,845
+19% +$952K 0.01% 517
2023
Q4
$5.38M Buy
224,409
+7,823
+4% +$170K 0.01% 541
2023
Q3
$4.74M Buy
216,586
+25,293
+13% +$529K 0.01% 549
2023
Q2
$3.66M Buy
+191,293
New +$3.69M 0.01% 618
2023
Q1
Sell
-26,861
Closed -$431K 1548
2022
Q4
$431K Buy
26,861
+5,036
+23% +$82.1K ﹤0.01% 976
2022
Q3
$342K Buy
+21,825
New +$422K ﹤0.01% 1042
2022
Q1
Sell
-86,408
Closed -$1.58M 1438
2021
Q4
$1.58M Sell
86,408
-83,200
-49% -$1.59M ﹤0.01% 807
2021
Q3
$3.59M Sell
169,608
-71,715
-30% -$1.33M 0.01% 636
2021
Q2
$4.4M Buy
241,323
+40,915
+20% +$954K 0.01% 585
2021
Q1
$4.53M Buy
+200,408
New +$4.53M 0.01% 556
2020
Q4
Sell
-10,588
Closed -$259K 1058
2020
Q3
$259K Sell
10,588
-4,168
-28% -$97.3K ﹤0.01% 897
2020
Q2
$350K Sell
14,756
-151,728
-91% -$3.52M ﹤0.01% 843
2020
Q1
$2.87M Sell
166,484
-218,897
-57% -$4M 0.01% 432
2019
Q4
$6.79M Buy
385,381
+374,480
+3,435% +$6.35M 0.02% 385
2019
Q3
$193K Sell
10,901
-19,464
-64% -$394K ﹤0.01% 962
2019
Q2
$649K Sell
30,365
-19,900
-40% -$417K ﹤0.01% 821
2019
Q1
$1.2M Buy
50,265
+6,196
+14% +$141K ﹤0.01% 892
2018
Q4
$867K Buy
44,069
+2,795
+7% +$49.8K ﹤0.01% 835
2018
Q3
$731K Buy
41,274
+12,876
+45% +$251K ﹤0.01% 817
2018
Q2
$611K Buy
28,398
+5,867
+26% +$121K ﹤0.01% 752
2018
Q1
$499K Buy
22,531
+6,461
+40% +$179K ﹤0.01% 736
2017
Q4
$489K Buy
16,070
+5,954
+59% +$158K ﹤0.01% 690
2017
Q3
$245K Buy
10,116
+1,963
+24% +$52.2K ﹤0.01% 580
2017
Q2
$201K Buy
+8,153
New +$173K ﹤0.01% 592

Other funds holding EXEL